These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1444227)
1. Relation between the hormonal and epidemiological aspects of ovarian cancer patients in Japan. Kodama M; Kodama T; Totani R; Suzuoki Y; Kodama M Anticancer Res; 1992; 12(5):1593-602. PubMed ID: 1444227 [TBL] [Abstract][Full Text] [Related]
2. [Characteristics of urinary steroid excretions in ovarian cancer patients]. Kodama M; Kodama T; Totani R; Suzuoki Y Gan No Rinsho; 1984 May; 30(5):501-4. PubMed ID: 6727050 [TBL] [Abstract][Full Text] [Related]
3. Nutrition and breast cancer risk in Japan. Kodama M; Kodama T; Miura S; Yoshida M Anticancer Res; 1991; 11(2):745-54. PubMed ID: 2064329 [TBL] [Abstract][Full Text] [Related]
4. The genesis of breast cancer is a two-step phenomenon. II. Dissociation of two biomarkers in cancer patients from a low risk area of Japan. Kodama M; Kodama T; Murakami M; Kobayashi S; Akita T; Nakamura Y Anticancer Res; 1992; 12(1):153-60. PubMed ID: 1567162 [TBL] [Abstract][Full Text] [Related]
6. Epidemiologic analysis of breast and gynecologic cancers. Hulka BS Prog Clin Biol Res; 1997; 396():17-29. PubMed ID: 9108587 [TBL] [Abstract][Full Text] [Related]
7. Possible implication of environmental hormones in the recent risk increase of cancers of the skin and the liver, but not of the female breast worldwide. Kodama M; Murakami M; Kodama T Anticancer Res; 1999; 19(1B):789-98. PubMed ID: 10216494 [TBL] [Abstract][Full Text] [Related]
8. Hormonal status of gastric cancer. II. Abnormal constitution of urinary steroids in gastric cancer patients. Kodama M; Kodama T; Kobayashi S; Kasugai T; Takagi H; Suga S Nutr Cancer; 1987; 9(4):251-63. PubMed ID: 3601690 [TBL] [Abstract][Full Text] [Related]
9. Relation between the hormonal and epidemiological aspects of esophageal cancer in Japan. Kodama M; Kodama T; Takagi I; Kodama M Anticancer Res; 1992; 12(5):1671-81. PubMed ID: 1444235 [TBL] [Abstract][Full Text] [Related]
10. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR; Gadducci A; Gambacciani M Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [TBL] [Abstract][Full Text] [Related]
11. Researchers can now investigate long-term effects of OCs on cancer. Rubin GL; Peterson HB Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Krajcik RA; Borofsky ND; Massardo S; Orentreich N Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045 [TBL] [Abstract][Full Text] [Related]
14. Interrelation between Western type cancers and non-Western type cancers as regards their risk variation in time and space. IV. Hormonal transition of Japanese women from the pro-cervical cancer age through the pro-endometrial cancer age to the pro-hypogonadism age. Kodama M; Kodama T; Murakami M; Akita T; Totani R; Miura S; Yoshida M; Kodama M Anticancer Res; 1992; 12(3):693-704. PubMed ID: 1622126 [TBL] [Abstract][Full Text] [Related]
15. The relationship between the epidemiological and hormonal aspects of 6 human neoplasias - An introduction to the concept of steroid carcinogenesis. Kodama M; Murakami M; Kodama T Oncol Rep; 1997; 4(2):371-80. PubMed ID: 21590062 [TBL] [Abstract][Full Text] [Related]
16. [Obesity, body fat distribution and the incidence of breast, cervical, endometrial and ovarian carcinomas]. Sönnichsen AC; Lindlacher U; Richter WO; Schwandt P Dtsch Med Wochenschr; 1990 Dec; 115(50):1906-10. PubMed ID: 2257779 [TBL] [Abstract][Full Text] [Related]
17. Adolescence, a critical stage for the genesis of female cancers (review). Kodama M; Kodama T Anticancer Res; 1981; 1(2):93-9. PubMed ID: 7051957 [TBL] [Abstract][Full Text] [Related]
18. Nonbreast second malignancies after treatment of primary breast cancer. Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919 [TBL] [Abstract][Full Text] [Related]
19. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk. Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144 [TBL] [Abstract][Full Text] [Related]
20. Use of HRT and the subsequent risk of cancer. Beral V; Banks E; Reeves G; Appleby P J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]